Since interferon signaling pathways are known to modify MHC class I antigen processing and presentation35 and since many cancers are known to have impairment in these systems36–39, we hypothesized that TNF-α/IFN-γ-induced placental-derived ASCs may be useful in treating cancer. Here, IFNG is linked to cancer.